Trial intelligence / Profile preview

Propofol during minimally invasive surfactant therapy in preterm infants with respiratory distress syndrome

NL-OMON40970Active, not recruiting

Sponsor
Neonatologie
Start
Feb 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of propofol in respiratory distress syndrome (RDS) (2 arms), sponsored by Neonatologie. Started Feb 2015; status: active, not recruiting.

02

Drugs

propofol
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on NL-OMON40970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON40970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call